Clinical Trial Update: Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II randomized study of mFOLFIRINOX with or without ramucirumab in advanced pancreatic cancer; results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ramucirumab (ramucirumab)
• mFOLFIRINOX

Snippet

Sponsor: Walid Shaib, MD | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-01-01